Physician profile
Victor Azer
NPI 1326202805
$4,864.73
in general payments reported to CMS, 2019-2025
16 companies · $260 in 2025
The $260 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $908 · 2020: $232 · 2021: $1,117 · 2022: $638 · 2023: $753 · 2024: $957 · 2025: $260.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,970.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,970.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $857.02 | 2019-2024 | Xarelto |
| Abbott Laboratories | $714.41 | 2019-2025 | Aveir, Cardiomems, Mitraclip |
| Boston Scientific Corporation | $543.08 | 2019-2022 | |
| Medtronic, INC. | $534.38 | 2023-2024 | Cobalt Dr Mri Surescan, Micra, Capsurefix Novus Mri Surescan |
| E.R. Squibb & Sons, L.L.C. | $361.28 | 2023-2025 | Camzyos |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $301.63 | 2019-2021 | |
| Medtronic Vascular, INC. | $298.78 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $250.00 | 2020-2024 | Jardiance |
| Novo Nordisk INC | $242.35 | 2024 | |
| Astrazeneca Pharmaceuticals LP | $212.05 | 2019-2021 | |
| Amgen INC. | $137.92 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $122.20 | 2024 | |
| Alnylam Pharmaceuticals INC. | $118.39 | 2021 | |
| Intra-Sana Laboratories | $115.13 | 2024 | Glycate, Reltone 200 Mg, Reltone 400 Mg |
| Kestra Medical Technology Services, INC. | $43.48 | 2024 | Assure Wcd |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lantheus Medical Imaging, INC. | $12.63 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Victor Azer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.